Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 553 to 559 of 559 entries
Sorted by: Best Match Show Resources per page
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells .

Frontiers in cell and developmental biology

Dwucet A, Pruss M, Cao Q, Tanriover M, Prabhu VV, Allen JE, Peraud A, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G.
PMID: 34900991
Front Cell Dev Biol. 2021 Nov 26;9:734699. doi: 10.3389/fcell.2021.734699. eCollection 2021.

The purpose of this study was to examine whether the imipridone ONC201/TIC10 affects the metabolic and proliferative activity of medulloblastoma cells

Cite
Dwucet A, Pruss M, Cao Q, et al. ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells . Front Cell Dev Biol. 2021;9:734699doi: 10.3389/fcell.2021.734699.
Dwucet, A., Pruss, M., Cao, Q., Tanriover, M., Prabhu, V. V., Allen, J. E., Peraud, A., Westhoff, M. A., Siegelin, M. D., Wirtz, C. R., & Karpel-Massler, G. (2021). ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells . Frontiers in cell and developmental biology, 9734699. https://doi.org/10.3389/fcell.2021.734699
Dwucet, Annika, et al. "ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells ." Frontiers in cell and developmental biology vol. 9 (2021): 734699. doi: https://doi.org/10.3389/fcell.2021.734699
Dwucet A, Pruss M, Cao Q, Tanriover M, Prabhu VV, Allen JE, Peraud A, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G. ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells . Front Cell Dev Biol. 2021 Nov 26;9:734699. doi: 10.3389/fcell.2021.734699. eCollection 2021. PMID: 34900991; PMCID: PMC8661473.
Copy Download .nbib Format: NLM
A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary.

Anaerobe

Sóki J, Wybo I, Wirth R, Hajdú E, Matuz M, Burián K.
PMID: 34800619
Anaerobe. 2021 Nov 18;73:102480. doi: 10.1016/j.anaerobe.2021.102480. Epub 2021 Nov 18.

The antimicrobial susceptibilities of Bacteroides strains isolated from the feces of imipenem-treated patients from Belgium and Hungary were compared with those isolated from the normal microbiota from these two and five other European countries and assessed. Of the 10...

Cite
Sóki J, Wybo I, Wirth R, et al. A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary. Anaerobe. 2021;73:102480doi: 10.1016/j.anaerobe.2021.102480.
Sóki, J., Wybo, I., Wirth, R., Hajdú, E., Matuz, M., Burián, K. (2021). A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary. Anaerobe, 73102480. https://doi.org/10.1016/j.anaerobe.2021.102480
Sóki, József, et al. "A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary." Anaerobe vol. 73 (2021): 102480. doi: https://doi.org/10.1016/j.anaerobe.2021.102480
Sóki J, Wybo I, Wirth R, Hajdú E, Matuz M, Burián K. A comparison of the antimicrobial resistance of fecal Bacteroides isolates and assessment of the composition of the intestinal microbiotas of carbapenem-treated and non-treated persons from Belgium and Hungary. Anaerobe. 2021 Nov 18;73:102480. doi: 10.1016/j.anaerobe.2021.102480. Epub 2021 Nov 18. PMID: 34800619.
Copy Download .nbib Format: NLM
Protein sources influence both apparent digestibility and gastrointestinal evacuation rate in juvenile slipper lobster (Thenus australiensis).

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology

Wirtz A, Carter CG, Codabaccus MB, Fitzgibbon QP, Townsend AT, Smith GG.
PMID: 34822975
Comp Biochem Physiol A Mol Integr Physiol. 2021 Nov 23;265:111121. doi: 10.1016/j.cbpa.2021.111121. Epub 2021 Nov 23.

Apparent digestibility and gastrointestinal evacuation rate were measured to assess the potential of five commercially available protein sources for their inclusion in feeds for juvenile slipper lobster, Thenus australiensis. Protein sources tested were fishmeal, krill meal, lupin meal, soybean...

Cite
Wirtz A, Carter CG, Codabaccus MB, et al. Protein sources influence both apparent digestibility and gastrointestinal evacuation rate in juvenile slipper lobster (Thenus australiensis). Comp Biochem Physiol A Mol Integr Physiol. 2021;265:111121doi: 10.1016/j.cbpa.2021.111121.
Wirtz, A., Carter, C. G., Codabaccus, M. B., Fitzgibbon, Q. P., Townsend, A. T., & Smith, G. G. (2021). Protein sources influence both apparent digestibility and gastrointestinal evacuation rate in juvenile slipper lobster (Thenus australiensis). Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 265111121. https://doi.org/10.1016/j.cbpa.2021.111121
Wirtz, Andrea, et al. "Protein sources influence both apparent digestibility and gastrointestinal evacuation rate in juvenile slipper lobster (Thenus australiensis)." Comparative biochemistry and physiology. Part A, Molecular & integrative physiology vol. 265 (2021): 111121. doi: https://doi.org/10.1016/j.cbpa.2021.111121
Wirtz A, Carter CG, Codabaccus MB, Fitzgibbon QP, Townsend AT, Smith GG. Protein sources influence both apparent digestibility and gastrointestinal evacuation rate in juvenile slipper lobster (Thenus australiensis). Comp Biochem Physiol A Mol Integr Physiol. 2021 Nov 23;265:111121. doi: 10.1016/j.cbpa.2021.111121. Epub 2021 Nov 23. PMID: 34822975.
Copy Download .nbib Format: NLM
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.

Cancers

Busse A, Mochmann LH, Spenke C, Arsenic R, Briest F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P.
PMID: 33228231
Cancers (Basel). 2020 Nov 19;12(11). doi: 10.3390/cancers12113448.

Checkpoint inhibitors have shown promising results in a variety of tumors; however, in neuroendocrine tumors (NET) and neuroendocrine carcinomas (NEC), low response rates were reported. We aimed herein to investigate the tumor immune microenvironment in NET/NEC to determine whether...

Cite
Busse A, Mochmann LH, Spenke C, et al. Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment. Cancers (Basel). 2020;12(11)doi: 10.3390/cancers12113448.
Busse, A., Mochmann, L. H., Spenke, C., Arsenic, R., Briest, F., Jöhrens, K., Lammert, H., Sipos, B., Kühl, A. A., Wirtz, R., Pavel, M., Hummel, M., Kaemmerer, D., Baum, R. P., & Grabowski, P. (2020). Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment. Cancers, 12(11), . https://doi.org/10.3390/cancers12113448
Busse, Antonia, et al. "Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment." Cancers vol. 12,11 (2020). doi: https://doi.org/10.3390/cancers12113448
Busse A, Mochmann LH, Spenke C, Arsenic R, Briest F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P. Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment. Cancers (Basel). 2020 Nov 19;12(11). doi: 10.3390/cancers12113448. PMID: 33228231; PMCID: PMC7699546.
Copy Download .nbib Format: NLM
Treatment of Urethral Strictures in Transmasculine Patients.

Journal of clinical medicine

Waterschoot M, Claeys W, Hoebeke P, Verla W, Waterloos M, Wirtz M, Buncamper M, Lumen N.
PMID: 34501359
J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173912.

BACKGROUND: Urethral strictures are a common complication after genital gender-affirming surgery (GGAS) in transmasculine patients. Studies that specifically focus on the management of urethral strictures are scarce. The aim of this systematic review is to collect all available evidence...

Cite
Waterschoot M, Claeys W, Hoebeke P, et al. Treatment of Urethral Strictures in Transmasculine Patients. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173912.
Waterschoot, M., Claeys, W., Hoebeke, P., Verla, W., Waterloos, M., Wirtz, M., Buncamper, M., & Lumen, N. (2021). Treatment of Urethral Strictures in Transmasculine Patients. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173912
Waterschoot, Mieke, et al. "Treatment of Urethral Strictures in Transmasculine Patients." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173912
Waterschoot M, Claeys W, Hoebeke P, Verla W, Waterloos M, Wirtz M, Buncamper M, Lumen N. Treatment of Urethral Strictures in Transmasculine Patients. J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173912. PMID: 34501359; PMCID: PMC8432136.
Copy Download .nbib Format: NLM
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.

Cancer management and research

Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, Otto W, Worst TS, Kriegmair MC, Erben P, Hartmann A, Wullich B, Wirtz RM, Wach S.
PMID: 34447272
Cancer Manag Res. 2021 Aug 20;13:6567-6578. doi: 10.2147/CMAR.S318893. eCollection 2021.

PURPOSE: Fibroblast growth factor receptor 3 (FGFR3) alterations are frequent in non-muscle-invasive bladder cancer (NMIBC), although current data regarding the prognostic and therapeutic relevance are inconsistent. We analyzed the prognostic role of FGFR3 mRNA expression in stage T1 NMIBC.PATIENTS...

Cite
Sikic D, Taubert H, Breyer J, et al. The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer. Cancer Manag Res. 2021;13:6567-6578doi: 10.2147/CMAR.S318893.
Sikic, D., Taubert, H., Breyer, J., Eckstein, M., Weyerer, V., Keck, B., Kubon, J., Otto, W., Worst, T. S., Kriegmair, M. C., Erben, P., Hartmann, A., Wullich, B., Wirtz, R. M., & Wach, S. (2021). The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer. Cancer management and research, 136567-6578. https://doi.org/10.2147/CMAR.S318893
Sikic, Danijel, et al. "The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer." Cancer management and research vol. 13 (2021): 6567-6578. doi: https://doi.org/10.2147/CMAR.S318893
Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, Otto W, Worst TS, Kriegmair MC, Erben P, Hartmann A, Wullich B, Wirtz RM, Wach S. The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer. Cancer Manag Res. 2021 Aug 20;13:6567-6578. doi: 10.2147/CMAR.S318893. eCollection 2021. PMID: 34447272; PMCID: PMC8384147.
Copy Download .nbib Format: NLM
Author Correction: Vertical migration by bulk phytoplankton sustains biodiversity and nutrient input to the surface ocean.

Scientific reports

Wirtz K, Smith SL.
PMID: 33911175
Sci Rep. 2021 Apr 28;11(1):9486. doi: 10.1038/s41598-021-88994-y.

No abstract available.

Cite
Wirtz K, Smith SL. Author Correction: Vertical migration by bulk phytoplankton sustains biodiversity and nutrient input to the surface ocean. Sci Rep. 2021;11(1):9486doi: 10.1038/s41598-021-88994-y.
Wirtz, K., & Smith, S. L. (2021). Author Correction: Vertical migration by bulk phytoplankton sustains biodiversity and nutrient input to the surface ocean. Scientific reports, 11(1), 9486. https://doi.org/10.1038/s41598-021-88994-y
Wirtz, Kai, and Smith, S Lan. "Author Correction: Vertical migration by bulk phytoplankton sustains biodiversity and nutrient input to the surface ocean." Scientific reports vol. 11,1 (2021): 9486. doi: https://doi.org/10.1038/s41598-021-88994-y
Wirtz K, Smith SL. Author Correction: Vertical migration by bulk phytoplankton sustains biodiversity and nutrient input to the surface ocean. Sci Rep. 2021 Apr 28;11(1):9486. doi: 10.1038/s41598-021-88994-y. PMID: 33911175; PMCID: PMC8081721.
Copy Download .nbib Format: NLM
Showing 553 to 559 of 559 entries